The authors are sincerely grateful to all the patients and healthy donors in the work, whose clinical blood samples contributed to the findings on the clinical value of CTC enumeration and HER2 expression on CTCs by Pep@MNP and ICC in advanced breast cancer. This evidence concerns the gene ERBB2 and intrahepatic cholangiocarcinoma.